Cargando…

Red Blood Cell Count: An Unrecognized Risk Factor for Nonalcoholic Fatty Liver Disease

OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) is becoming a global public health challenge. A convenient NAFLD indicator will greatly facilitate risk appraisal and prevention. As a readily available and inexpensive hematological index in routine clinical examinations, red blood cells (RBCs) ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhong, Fang, Guan, Liying, Lin, Haiyan, Zhao, Meng, Qin, Yiming, Li, Qihang, Yuan, Zhongshang, Yang, Guang, Gao, Ling, Zhao, Jiajun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688742/ https://www.ncbi.nlm.nih.gov/pubmed/34950103 http://dx.doi.org/10.3389/fendo.2021.760981

Ejemplares similares

Association Between the Triglyceride–Glucose Index and Outcomes of Nonalcoholic Fatty Liver Disease: A Large-Scale Health Management Cohort Study
por: Liu, Jing, et al.
Publicado: (2021)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Clinical characterization and proteomic profiling of lean nonalcoholic fatty liver disease
por: Jiang, Yuanye, et al.
Publicado: (2023)

Statin Use and Benefits of Thyroid Function: A Retrospective Cohort Study
por: Wang, Yupeng, et al.
Publicado: (2021)

Role of extracellular vesicles in nonalcoholic fatty liver disease
por: Jiang, Wei, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease represents a greater metabolic burden in patients with atherosclerosis: A cross-sectional study
por: Han, Jie, et al.
Publicado: (2019)

High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women
por: Li, Qihang, et al.
Publicado: (2021)

Corrigendum: High Circulating Follicle-Stimulating Hormone Level Is a Potential Risk Factor for Renal Dysfunction in Post-Menopausal Women
por: Li, Qihang, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease in University Rugby Football Players
por: Nirengi, Shinsuke, et al.
Publicado: (2018)

The impact of obstructive sleep apnea on nonalcoholic fatty liver disease
por: Tang, Haiying, et al.
Publicado: (2023)

Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease‐related cirrhosis is commonly unrecognized and associated with hepatocellular carcinoma
por: Bertot, Luis C., et al.
Publicado: (2017)

Corrigendum: Regulatory network and interplay of hepatokines, stellakines, myokines and adipokines in nonalcoholic fatty liver diseases and nonalcoholic steatohepatitis
por: Yang, Bing, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population
por: Ciardullo, Stefano, et al.
Publicado: (2021)

Decreased Sclerostin Secretion in Humans and Mice With Nonalcoholic Fatty Liver Disease
por: Zhou, Fangli, et al.
Publicado: (2021)

Which is the optimal antiobesity agent for patients with nonalcoholic fatty liver disease?
por: Tsankof, Alexandra, et al.
Publicado: (2022)

Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease
por: Zhao, Yanhua, et al.
Publicado: (2022)

Serum IL-27 levels increase in subjects with hypothyroidism and are negatively correlated with the occurrence of nonalcoholic fatty liver disease
por: Wen, Yahui, et al.
Publicado: (2023)

Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms
por: Takahashi, Hirokazu, et al.
Publicado: (2018)

Complex impacts of gallstone disease on metabolic syndrome and nonalcoholic fatty liver disease
por: Lyu, Jingting, et al.
Publicado: (2022)

Association between different obesity phenotypes and hypothyroidism: a study based on a longitudinal health management cohort
por: Wang, Yupeng, et al.
Publicado: (2021)

The triglyceride and glucose index and risk of nonalcoholic fatty liver disease: A dose–response meta-analysis
por: Ling, Qin, et al.
Publicado: (2023)

Association of Nonalcoholic Fatty Liver Disease With Osteoporotic Fractures: A Cross-Sectional Retrospective Study of Chinese Individuals
por: Wang, Yanmao, et al.
Publicado: (2018)

MiR-200c-3p Regulates DUSP1/MAPK Pathway in the Nonalcoholic Fatty Liver After Laparoscopic Sleeve Gastrectomy
por: Zhang, Tao-tao, et al.
Publicado: (2022)

Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
por: Zhou, Xuelian, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease is specifically related to the risk of hepatocellular cancer but not extrahepatic malignancies
por: Albhaisi, Somaya, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
por: Yu, Yuetian, et al.
Publicado: (2023)

Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Xia, Jinying, et al.
Publicado: (2022)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuyuan, et al.
Publicado: (2022)

Transcriptomic profiling of hepatic tissues for drug metabolism genes in nonalcoholic fatty liver disease: A study of human and animals
por: Chen, Li, et al.
Publicado: (2023)

Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients
por: Liu, Lu, et al.
Publicado: (2017)

Associations Between Abdominal Obesity Indices and Nonalcoholic Fatty Liver Disease: Chinese Visceral Adiposity Index
por: Chen, Xueyu, et al.
Publicado: (2022)

Causal effects of nonalcoholic fatty liver disease on cerebral cortical structure: a Mendelian randomization analysis
por: Mai, Zhiliang, et al.
Publicado: (2023)

Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy
por: Ma, Junli, et al.
Publicado: (2017)

Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese
por: Jiang, Li-Peng, et al.
Publicado: (2022)

Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy
por: Friesen, Chance S., et al.
Publicado: (2021)

Nonalcoholic fatty liver disease in children with obesity– observations from one clinical centre in the Western Pomerania region
por: Marcinkiewicz, Katarzyna, et al.
Publicado: (2022)

Pattern recognition receptors in the development of nonalcoholic fatty liver disease and progression to hepatocellular carcinoma: An emerging therapeutic strategy
por: Huang, Chen, et al.
Publicado: (2023)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lkgmjh7l8md27lne9a7rmn7atj